MedTrace Logo

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

NCT00005095 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2025-02-28

No results posted yet for this study

Summary

RATIONALE: To improve strategies for detection and prevention of early-stage disease.

PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.

Conditions

Interventions

OTHER

Ca-125

Subject's blood collected at their follow-up blood draw will be assessed for biomarkers that could lead to a panel for detecting early stage ovarian cancer.

OTHER

screening questionnaire administration

Questionnaires designed to assess quality of life for women at increased risk of ovarian cancer will be administered to the subjects. Clinical data will also be collected.

PROCEDURE

Surgery

Subjects will be assessed for high risk factors.

Sponsors & Collaborators

Principal Investigators

  • Lee P. Shulman, MD · Robert H. Lurie Cancer Center

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-03-31
Primary Completion
2030-12-31
Completion
2040-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005095 on ClinicalTrials.gov